GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ProMIS Neurosciences Inc (FRA:23J0) » Definitions » Accumulated other comprehensive income (loss)

ProMIS Neurosciences (FRA:23J0) Accumulated other comprehensive income (loss) : €-0.34 Mil (As of Mar. 2025)


View and export this data going back to 2017. Start your Free Trial

What is ProMIS Neurosciences Accumulated other comprehensive income (loss)?

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings. ProMIS Neurosciences's Accumulated other comprehensive income (loss) for the quarter that ended in Mar. 2025 was €-0.34 Mil.

ProMIS Neurosciences's quarterly Accumulated other comprehensive income (loss) declined from Sep. 2024 (€-0.33 Mil) to Dec. 2024 (€-0.35 Mil) but then increased from Dec. 2024 (€-0.35 Mil) to Mar. 2025 (€-0.34 Mil).

ProMIS Neurosciences's annual Accumulated other comprehensive income (loss) declined from Dec. 2022 (€-0.18 Mil) to Dec. 2023 (€-0.34 Mil) and declined from Dec. 2023 (€-0.34 Mil) to Dec. 2024 (€-0.35 Mil).

ProMIS Neurosciences Accumulated other comprehensive income (loss) Historical Data

The historical data trend for ProMIS Neurosciences's Accumulated other comprehensive income (loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ProMIS Neurosciences Accumulated other comprehensive income (loss) Chart

ProMIS Neurosciences Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Accumulated other comprehensive income (loss)
Get a 7-Day Free Trial Premium Member Only Premium Member Only - -0.17 -0.18 -0.34 -0.35

ProMIS Neurosciences Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Accumulated other comprehensive income (loss) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.34 -0.35 -0.33 -0.35 -0.34

ProMIS Neurosciences Accumulated other comprehensive income (loss) Calculation

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings.

ProMIS Neurosciences Accumulated other comprehensive income (loss) Related Terms

Thank you for viewing the detailed overview of ProMIS Neurosciences's Accumulated other comprehensive income (loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

ProMIS Neurosciences Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ProMIS Neurosciences Inc (FRA:23J0) » Definitions » Accumulated other comprehensive income (loss)
Comparable Companies
SABS IMNN GLYC VYNE CING ALLR MTVA GOVX LPTX XFOR VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
PMN:USA 23J0:Germany
Address
1920 Yonge Street, Suite 200, Toronto, ON, CAN, M4S 3E2
Website
https://www.promisneurosciences.com
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.

ProMIS Neurosciences Headlines

No Headlines